Are the MORECare guidelines on reporting of attrition in palliative care research populations appropriate? A systematic review and meta-analysis of randomised controlled trials.

Anna OrianiLesley DunleavyPaul SharplesGuillermo Perez AlgortaNancy J Preston

Published in: BMC palliative care (2020)

Reporting the cause of attrition is useful in helping to understand trial results. Prospective reporting using the MORECare classifications should improve our understanding of future trials.

Keyphrases

palliative care
adverse drug
study protocol
current status
emergency department
randomized controlled trial
phase ii
electronic health record